Number of trial omissions over 200 trials and average response latencies following inactivation and vehicle treatments in different regions of the OFC and medial PFC
| Saline | Inactivation | |
|---|---|---|
| Probabilistic reversals | ||
| Orbitofrontal | ||
| mOFC | ||
| Trial omissions | 10.9 (3.9) | 8.2 (3.1) |
| Response latency(s) | 1.0 (0.2) | 1.0 (0.1) |
| lOFC | ||
| Trial omissions | 9.2 (2.9) | 21.5 (5.1)* |
| Response latency | 1.0 (0.1) | 1.5 (0.2)* |
| Medial prefrontal | ||
| Prelimbic | ||
| Trial omissions | 3.3 (2.0) | 1.4 (0.8) |
| Response latency | 0.7 (0.1) | 0.6 (0.1) |
| Infralimbic | ||
| Trial omissions | 10.2 (2.9) | 11.5 (5.7) |
| Response latency | 1.0 (0.1) | 0.9 (0.1) |
| Anterior cingulate | ||
| Trial omissions | 11.0 (5.3) | 22.4 (8.5) |
| Response latency | 0.8 (0.1) | 1.2 (0.2)* |
| Reversals w/assured outcomes | ||
| mOFC | ||
| Trial omissions | 3.0 (1.0) | 7.8 (4.3) |
| Response latency | 0.9 (0.1) | 0.9 (0.1) |
| lOFC | ||
| Trial omissions | 1.0 (0.6) | 9.8 (4.2) |
| Response latency | 0.7 (0.1) | 1.1 (0.2)* |
Values are displayed as mean (SEM).
↵*p < 0.05.